Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ferric derisomaltose (Monoferric) (4 trials)
iron dextran (INFeD) (1 trial)
red blood cells (1 trial)
sodium chloride (1 trial)
Anemia (Phase 3)
Anemia, Iron-Deficiency (Phase 3)
Deficiency Diseases (Phase 3)
Hemorrhage (Phase 3)
Postpartum Hemorrhage (Phase 3)
Psychomotor Agitation (Phase 2)
Restless Legs Syndrome (Phase 2)
Syndrome (Phase 2)
Trials (4 total)
Trial APIs (4 total)